Assessing the minimal invasiveness of pure single-incision da Vinci SP surgery for right-sided colon cancer: comparative analysis with the da Vinci Xi system using PSM and IPTW - Scorecard - MDSpire

Assessing the minimal invasiveness of pure single-incision da Vinci SP surgery for right-sided colon cancer: comparative analysis with the da Vinci Xi system using PSM and IPTW

  • By

  • Sohei Akuta

  • Yasumitsu Hirano

  • Yasuhiro Ishiyama

  • Yume Minagawa

  • Yusuke Nishi

  • Hisashi Hayashi

  • Akihito Nakanishi

  • Takatsugu Fujii

  • Hirofumi Sugita

  • Chikashi Hiranuma

  • Yusuke Kinugasa

  • March 10, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Minimally Invasive Nature of Pure Single-Incision da Vinci SP Surgery for Right-Sided Colon Cancer: A Comparative Study with the da Vinci Xi System Utilizing PSM and IPTW

At a Glance

CategoryDetail
ConditionRight-sided colon cancer
Key MechanismsComparison of pure single-incision robotic surgery using da Vinci SP system without assistant ports versus da Vinci Xi system; assessment of minimal invasiveness via postoperative pain (NRS) and inflammation (CRP/Alb ratio)
Target PopulationPatients undergoing ileocecal resection or right hemicolectomy for right-sided colon cancer
Care SettingSingle-center, retrospective observational study in a surgical oncology setting with certified robotic surgeons

Key Highlights

  • Pure single-incision da Vinci SP surgery performed without additional assistant ports represents a novel approach emphasizing minimal invasiveness.
  • Postoperative pain (NRS) and CRP/Alb ratio used as objective indicators to evaluate surgical invasiveness and recovery.
  • Propensity score matching and inverse probability of treatment weighting applied to minimize selection bias in comparing SP and Xi systems.

Guideline-Based Recommendations

Diagnosis

  • Right-sided colon cancer diagnosis based on tumor location including appendiceal, cecal, ascending, and transverse colon cancers.
  • Exclude patients with prior chemoradiotherapy, recurrent/multiple cancers, emergency surgery, or non-certified surgeons.

Management

  • Perform ileocecal resection or right hemicolectomy using da Vinci SP or Xi robotic systems.
  • Use a 3-cm umbilical incision for SP surgery without additional assistant ports.
  • Employ intracorporeal medial-to-lateral dissection with ligation of ileocolic vessels and lymphadenectomy.
  • Manage patients under standardized enhanced recovery after surgery (ERAS) protocols including scheduled acetaminophen and on-demand NSAIDs or opioids.

Monitoring & Follow-up

  • Assess postoperative pain using Numerical Rating Scale (NRS) three times daily by trained nursing staff.
  • Monitor postoperative inflammation and nutritional status using C-reactive protein/albumin (CRP/Alb) ratio.
  • Classify postoperative complications according to Clavien–Dindo system, considering grade II or higher as clinically significant.

Risks

  • Potential technical constraints related to instrument triangulation and learning curve effects with SP system.
  • Limited availability of integrated energy devices and robotic staplers in SP system may require adaptation.
  • Risk of intraoperative complications and conversion to laparotomy should be monitored.

Patient & Prescribing Data

Patients undergoing robotic-assisted surgery for right-sided colon cancer at a tertiary medical center.

Pure single-incision SP surgery without assistant ports may reduce postoperative pain and inflammation comparable to or better than Xi system, supporting its feasibility and safety.

Clinical Best Practices

  • Ensure surgeons are certified and experienced with robotic colorectal surgery, having completed at least 20 Xi procedures before SP use.
  • Apply propensity score matching and inverse probability of treatment weighting in retrospective analyses to reduce bias.
  • Utilize standardized ERAS protocols to optimize postoperative recovery and pain management.
  • Perform all SP procedures as solo surgeries through a single umbilical incision to maximize minimal invasiveness benefits.

References

Original Source(s)

Related Content